A5009104471- Antibiotic Resistance in Bacteria
- Antibiotic Use and Resistance
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases and Mycology
- Plant Pathogenic Bacteria Studies
- Pneumonia and Respiratory Infections
- Antimicrobial Resistance in Staphylococcus
- Mycobacterium research and diagnosis
- Tuberculosis Research and Epidemiology
- Pharmaceutical and Antibiotic Environmental Impacts
- Microbial Community Ecology and Physiology
- Escherichia coli research studies
- Vibrio bacteria research studies
- Antibiotics Pharmacokinetics and Efficacy
Smolensk State Medical University
2021-2023
Background: Acinetobacter species other than A. baumannii are becoming increasingly more important as opportunistic pathogens for humans. The primary aim of this study was to assess the prevalence, distribution, antimicrobial resistance patterns, and carbapenemase gene content clinical non-baumannii (Anb) isolates that were collected part a sentinel surveillance program bacterial infections in hospitalized patients. secondary evaluate performance MALDI-TOF MS systems species-level...
Objective. To assess the in vitro activity of ceftazidime-avibactam against clinical Enterobacterales and Pseudomonas aeruginosa isolates various regions Russia based on results local susceptibility testing by disk diffusion method. Materials Methods. Overall, 160 laboratories located 61 Russian cities participated this surveillance during 2018-2020. All consecutive each participating laboratory were included study. Ceftazidime-avibactam was done disc-diffusion method accordance with current...
Objective. To evaluate in vitro activity of biapenem and other clinically available carbapenems against Russian clinical isolates Enterobacterales, Pseudomonas aeruginosa и Acinetobacter spp., including with acquired fermentative mechanisms resistance to β-lactams. Materials Methods. A total 3139 Enterobacterales isolates, 793 P. 634 spp. from hospitalized patients 63 hospitals 35 cities were included the study during 2018-2019. Minimal inhibitory concentrations (MIC) for antimicrobials...
Non-tuberculous mycobacteria (NTM) include more than 190 species and subspecies. Some NTM can cause human diseases of the lungs or extrapulmonary infections. The guidelines focus on pulmonary mycobacteriosis in adult patients without cystic fibrosis HIV infection caused by most common NTMs, such as Mycobacterium avium complex, kansasii, xenopi among slow-growing NTMs abscessus complex fast-growing species. Experts American Thoracic Society (ATS), European Respiratory (ERS), for Clinical...